PL3634379T3 - Szybko rozpadający się opłatek piankowy o dużej masie powierzchniowej - Google Patents

Szybko rozpadający się opłatek piankowy o dużej masie powierzchniowej

Info

Publication number
PL3634379T3
PL3634379T3 PL18731023.0T PL18731023T PL3634379T3 PL 3634379 T3 PL3634379 T3 PL 3634379T3 PL 18731023 T PL18731023 T PL 18731023T PL 3634379 T3 PL3634379 T3 PL 3634379T3
Authority
PL
Poland
Prior art keywords
per unit
unit area
mass per
high mass
quickly disintegrating
Prior art date
Application number
PL18731023.0T
Other languages
English (en)
Inventor
Markus Müller
Marius Bauer
Michael Linn
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of PL3634379T3 publication Critical patent/PL3634379T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18731023.0T 2017-06-07 2018-06-07 Szybko rozpadający się opłatek piankowy o dużej masie powierzchniowej PL3634379T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017112527.2A DE102017112527B4 (de) 2017-06-07 2017-06-07 Schnell zerfallende Schaumwafer mit hohem Flächengewicht
PCT/EP2018/065008 WO2018224591A1 (de) 2017-06-07 2018-06-07 Schnell zerfallende schaumwafer mit hohem flächengewicht

Publications (1)

Publication Number Publication Date
PL3634379T3 true PL3634379T3 (pl) 2025-01-20

Family

ID=62599569

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18731023.0T PL3634379T3 (pl) 2017-06-07 2018-06-07 Szybko rozpadający się opłatek piankowy o dużej masie powierzchniowej

Country Status (13)

Country Link
US (1) US20200138714A1 (pl)
EP (1) EP3634379B1 (pl)
JP (3) JP7471823B2 (pl)
KR (1) KR102398857B1 (pl)
CN (1) CN110709064A (pl)
AU (1) AU2018281944B2 (pl)
CA (1) CA3064168C (pl)
DE (1) DE102017112527B4 (pl)
ES (1) ES2987507T3 (pl)
MX (1) MX379760B (pl)
PL (1) PL3634379T3 (pl)
RU (1) RU2019144316A (pl)
WO (1) WO2018224591A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017129012A1 (de) 2017-12-06 2019-06-06 Lts Lohmann Therapie-Systeme Ag Oraler Dünnfilm mit hoher Wirkstoffbeladung
ES2907692T3 (es) 2017-12-29 2022-04-26 Celon Pharma Sa Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento
EP3895691A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Ulipristal acetate otf
US20230210789A1 (en) * 2020-06-02 2023-07-06 Ix Biopharma Limited Methods for treating major depressive disorder and treatment-resistant depression
JP2023548215A (ja) * 2020-11-09 2023-11-15 エルテーエス ローマン テラピー-ジステーメ アーゲー 経口薄フィルム
DE102021120937A1 (de) * 2021-08-11 2023-02-16 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
DE102021100752A1 (de) * 2021-01-15 2022-07-21 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
DE102021106491A1 (de) 2021-03-17 2022-09-22 Lts Lohmann Therapie-Systeme Ag. Gerollte oral thin films mit hoher wirkstoffbeladung
EP4151204A1 (de) * 2021-09-17 2023-03-22 LTS Lohmann Therapie-Systeme AG Schnell zerfallende orale dünne filme/schäume mit hoher wirkstoffbeladung auf basis eines gemisches von polyvinylalkoholen mit unterschiedlichen molekulargewichten
EP4302750A1 (en) 2022-07-07 2024-01-10 LTS Lohmann Therapie-Systeme AG Oral thin films comprising adrenaline

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
BR9205864A (pt) * 1991-04-08 1994-06-28 Sumitomo Pharma Formulações sólidas porosas contendo substâncias proteináceas fisiologicamente ativas.
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
US5458884A (en) * 1992-09-10 1995-10-17 Britton; Peter Bioerodible device for administering active ingredients
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain
US20010006677A1 (en) 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19652257A1 (de) 1996-12-16 1998-06-18 Lohmann Therapie Syst Lts Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6090401A (en) * 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
DE10032456A1 (de) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
KR20110004921A (ko) * 2002-05-16 2011-01-14 규큐 야쿠힝 고교 가부시키가이샤 속용성 필름형상 제제
EP2716284A3 (en) * 2003-05-28 2014-11-05 MonoSol RX LLC Polyethylene oxide-based films and drug delivery systems made herefrom
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
US8765170B2 (en) * 2008-01-30 2014-07-01 The Procter & Gamble Company Personal care composition in the form of an article
US9265779B2 (en) * 2008-05-13 2016-02-23 Lts Lohmann Therapie-Systeme Ag Method of using a film-shaped preparation comprising oily substances for oral administration
CN103025321A (zh) * 2010-03-23 2013-04-03 生物联合制药公司 快速溶解的药物释放系统
JP2013526561A (ja) * 2010-05-21 2013-06-24 ビーエーエスエフ ソシエタス・ヨーロピア 両親媒性コポリマーを基材とする拡大した表面積を有する生物学的活性物質の製剤
BR112013031406B1 (pt) * 2011-06-08 2022-02-22 Lts Lohmann Therapie-Systeme Ag Tira de filme oral comestível e seu método de preparação
US11207316B2 (en) * 2014-05-30 2021-12-28 West Virginia University Ketamine or dextromethorphan formulations and methods of use
JP2023548215A (ja) * 2020-11-09 2023-11-15 エルテーエス ローマン テラピー-ジステーメ アーゲー 経口薄フィルム

Also Published As

Publication number Publication date
DE102017112527B4 (de) 2019-01-03
JP2024069308A (ja) 2024-05-21
AU2018281944A1 (en) 2020-01-02
AU2018281944B2 (en) 2021-09-23
KR20200013762A (ko) 2020-02-07
JP7471823B2 (ja) 2024-04-22
CA3064168A1 (en) 2018-12-13
JP2020530433A (ja) 2020-10-22
WO2018224591A1 (de) 2018-12-13
MX2019014738A (es) 2020-02-07
MX379760B (es) 2025-03-11
BR112019024798A2 (pt) 2020-06-09
EP3634379B1 (de) 2024-08-28
KR102398857B1 (ko) 2022-05-16
EP3634379A1 (de) 2020-04-15
CN110709064A (zh) 2020-01-17
US20200138714A1 (en) 2020-05-07
RU2019144316A3 (pl) 2021-07-09
JP2022095893A (ja) 2022-06-28
RU2019144316A (ru) 2021-07-09
CA3064168C (en) 2023-02-28
ES2987507T3 (es) 2024-11-15
DE102017112527A1 (de) 2018-12-13

Similar Documents

Publication Publication Date Title
PL3634379T3 (pl) Szybko rozpadający się opłatek piankowy o dużej masie powierzchniowej
IL249661A0 (en) Foam containing a heterogeneous mass
PL3728367T3 (pl) Sztywne pianki
IL248706A0 (en) Heterogeneous mass containing foam
IL249081A0 (en) Heterogeneous mass containing foam
GB2560640B (en) Portable cushioned support
AU362948S (en) Oscillating mass
EP3290122A4 (en) Foam discharge device
ES3064185T3 (en) Lipid-based foam
PT3395218T (pt) Triturador refrigerado
GB201701740D0 (en) Phased convective operation
GB2565725B (en) Resilient high bulk towels
GB201819533D0 (en) Foam machine
GB201603949D0 (en) Foam dispensers
PT3373781T (pt) Dispositivo de formação de espuma
GB2566203B (en) Foam discharge container
PL3600675T3 (pl) Urządzenie rozdrabniające
PL3172991T3 (pl) Poduszka
GB201616067D0 (en) Footwear having memory foam
GB201509828D0 (en) Foam dispensers
AU201812008S (en) Graters
GB201512095D0 (en) Structures Fabricated Using Foam Elements
AU361625S (en) Coconut cup
PL3307205T3 (pl) Urządzenie do stabilizacji szyjki macicy
PL3579976T3 (pl) Urządzenie rozdrabniające